Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 2 |
2006 | 1 |
2007 | 2 |
2008 | 2 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Clinical applications for targeted therapy in bladder cancer.
Urol Clin North Am. 2005 May;32(2):239-46, vii. doi: 10.1016/j.ucl.2005.02.004.
Urol Clin North Am. 2005.
PMID: 15862621
Review.
Schedule dependent efficacy of gefitinib and docetaxel for bladder cancer.
Kassouf W, Luongo T, Brown G, Adam L, Dinney CP.
Kassouf W, et al.
J Urol. 2006 Aug;176(2):787-92. doi: 10.1016/j.juro.2006.03.072.
J Urol. 2006.
PMID: 16813948
Item in Clipboard
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.
Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP.
Kassouf W, et al.
J Urol. 2008 Jan;179(1):353-8. doi: 10.1016/j.juro.2007.08.087. Epub 2007 Nov 19.
J Urol. 2008.
PMID: 18006009
Free PMC article.
Item in Clipboard
Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?
Kassouf W, Brown GA, Black PC, Fisher MB, Inamoto T, Luongo T, Gallagher D, Bar-Eli M, McConkey DJ, Adam L, Dinney CP.
Kassouf W, et al.
J Urol. 2008 Sep;180(3):1146-53. doi: 10.1016/j.juro.2008.05.001. Epub 2008 Jul 18.
J Urol. 2008.
PMID: 18639280
Free PMC article.
Item in Clipboard
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer.
Black PC, Brown GA, Dinney CP, Kassouf W, Inamoto T, Arora A, Gallagher D, Munsell MF, Bar-Eli M, McConkey DJ, Adam L.
Black PC, et al.
J Urol. 2011 Feb;185(2):693-700. doi: 10.1016/j.juro.2010.09.082. Epub 2010 Dec 18.
J Urol. 2011.
PMID: 21168861
Item in Clipboard
Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.
Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L.
Kassouf W, et al.
Cancer Res. 2005 Nov 15;65(22):10524-35. doi: 10.1158/0008-5472.CAN-05-1536.
Cancer Res. 2005.
PMID: 16288045
Item in Clipboard
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, Benedict WF, Dinney CP.
Adam L, et al.
J Urol. 2007 May;177(5):1900-6. doi: 10.1016/j.juro.2007.01.003.
J Urol. 2007.
PMID: 17437845
Item in Clipboard
Cite
Cite